Evidence map›Paper›PMID 42724824›Full record

ArticleTranslational cancer research2026

Association between primary tumor surgery and survival in patients with

Ruizhe Yue, Zheng Wang, Hao Zhang

Abstract read
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ruizhe YueDepartment of Breast Surgery, Affiliated Nanyang Central Hospital of Henan Medical University, Nanyang, China.ORCID https://orcid.org/0009-0000-2007-7708
Zheng WangDepartment of Breast Surgery, Affiliated Nanyang Central Hospital of Henan Medical University, Nanyang, China.
Hao ZhangDepartment of Breast Surgery, Affiliated Nanyang Central Hospital of Henan Medical University, Nanyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The role of primary tumor surgery in patients with Methods: Female patients diagnosed with Results: A total of 1,827 patients were included, of whom 543 underwent primary tumor surgery and 1,284 did not. After 1:1 PSM, 507 matched pairs were generated. After matching, the median OS was 15 months in the surgery group and 9 months in the non-surgery group, while the median BCSS was 15 months and 10 months, respectively. In multivariable Cox analysis, primary tumor surgery was independently associated with longer OS [hazard ratio (HR) =0.532, 95% confidence interval (CI): 0.462-0.612, P<0.001] and BCSS (HR =0.544, 95% CI: 0.470-0.629, P<0.001). These associations remained stable in robust Cox sensitivity analyses. RMST analyses at 24 and 36 months further supported the robustness of the observed survival association. Conclusions: Primary tumor surgery was associated with longer OS and BCSS in patients with

Indexed as

de novo stage IVprimary tumor surgerySurveillance, Epidemiology, and End Results database (SEER database)Triple-negative breast cancer (TNBC)visceral metastasis

Identifiers

PMID42724824
PMCPMC13559625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.